121 related articles for article (PubMed ID: 8846808)
1. The electrophysiologic effects of ersentilide on canine hearts.
Lee JH; Rosenshtraukh L; Beloshapko G; Rosen MR
Eur J Pharmacol; 1995 Oct; 285(1):25-35. PubMed ID: 8846808
[TBL] [Abstract][Full Text] [Related]
2. Cardiac effects of cibenzoline.
Dangman KH
J Cardiovasc Pharmacol; 1984; 6(2):300-11. PubMed ID: 6200720
[TBL] [Abstract][Full Text] [Related]
3. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
Damiano BP; Stump GL; Yagel SK
J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects of alprafenone on canine cardiac tissue.
Anyukhovsky EP; Rosen MR
J Cardiovasc Pharmacol; 1994 Sep; 24(3):411-9. PubMed ID: 7528297
[TBL] [Abstract][Full Text] [Related]
5. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
Gibson JK; Gelband H; Bassett AL
J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ
J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
[TBL] [Abstract][Full Text] [Related]
8. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
Nakaya H; Kimura S; Nakao Y; Kanno M
Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic effects of McN-4130, a new antiarrhythmic compound, on isolated cardiac tissue.
Damiano BP; Brannan MD
J Cardiovasc Pharmacol; 1987 Nov; 10(5):498-508. PubMed ID: 2447397
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects of AHR 10718 on isolated cardiac tissues.
Damiano BP; Le Marec H; Rosen MR
Eur J Pharmacol; 1985 Feb; 108(3):243-55. PubMed ID: 3838726
[TBL] [Abstract][Full Text] [Related]
11. Cardiac electrophysiologic effects of R 54718.
Johnson N; Spinelli W; Rosen MR
Eur J Pharmacol; 1987 Mar; 135(1):41-51. PubMed ID: 3569425
[TBL] [Abstract][Full Text] [Related]
12. Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
Ikeda N; Singh BN; Davis LD; Hauswirth O
J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):303-10. PubMed ID: 3968315
[TBL] [Abstract][Full Text] [Related]
13. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ
Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317
[TBL] [Abstract][Full Text] [Related]
14. Barucainide, a novel class Ib antiarrhythmic agent with a slow kinetic property: electrophysiologic observations in isolated canine and rabbit cardiac muscle.
Takanaka C; Singh BN
Am Heart J; 1990 May; 119(5):1050-60. PubMed ID: 2330863
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic regulation of action potentials and automaticity in young and adult canine purkinje fibers.
Charpentier F; Rosen MR
Am J Physiol; 1994 Jun; 266(6 Pt 2):H2310-9. PubMed ID: 7912899
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
Patterson E; Scherlag BJ; Berlin KD; Lazzara R
J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
[TBL] [Abstract][Full Text] [Related]
17. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
18. Class III electrophysiologic actions of imidazole-substituted diheterabicyclononanes in canine myocardium.
Patterson E; Scherlag BJ; Sangiah S; Garrison GL; Couch KM; Berlin KD; Lazzara R
J Pharmacol Exp Ther; 1997 Apr; 281(1):155-62. PubMed ID: 9103493
[TBL] [Abstract][Full Text] [Related]
19. Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
Kato R; Singh BN
Am Heart J; 1986 Feb; 111(2):271-9. PubMed ID: 3484892
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological effects of dridocainide on isolated canine, guinea-pig and human cardiac tissues.
Pankucsi C; Hegedüs M; Kovács A; Szénási G; Szemerédi K; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):520-8. PubMed ID: 8751081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
